The Endoret® (prgf®) technology represents a new milestone in the development and use of autologous biological therapies for tissue repair and regeneration.

Over more than 15 years, it has been possible to verify the safety and therapeutic potential of the different Endoret® (prgf®) formulations in different areas of medicine. A knowledge, a safety and an effectiveness that now reach the field of ophthalmology. The set of Endoret® (prgf®) technology formulations represents a solution in terms of safety, effectiveness and reproducibility that ophthalmologists demanded in the treatment of various eye diseases.